SCHEMBL6229229

SCHEMBL6229229

O=C1CC2(CCCCCC2)CN1

nearest known ligand 0.46

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.46
OPRL1 P41146 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.41
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
LRRK2 Q5S007 1/20 0.32
CRBN Q96SW2 1/20 0.31
PRMT1 Q99873 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL483007 1.00 OPRM1 (0.46) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL4339042 0.98 OPRM1 (0.45) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL2522078 0.98 OPRM1 (0.47) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL4956385 0.93 OPRM1 (0.49) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL17925986 0.93
SCHEMBL16190003 0.87
SCHEMBL4289914 0.82 SMN1; SMN2 (0.50) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL20941858 0.81 OPRM1 (0.41) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
Hydrochloric Acid SCHEMBL17101303 0.80 OPRM1 (0.40) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2
SCHEMBL2106280 0.79 OPRM1 (0.45) OPRM1OPRL1SMN1; SMN2CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3237903-B1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RES & ENG CO (US) 2020-02-26 EP claimed
EP-3237904-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS Exxonmobil Research And Engineering Company (US) 2017-11-01 EP claimed
EP-3237903-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS Exxonmobil Research And Engineering Company (US) 2017-11-01 EP claimed
WO-2016106214-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 WO claimed
US-20160187315-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 US claimed
US-20160187314-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 US claimed
WO-2016106211-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 WO claimed
EP-3237903-B1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RES & ENG CO (US) 2020-02-26 EP disclosed
EP-3237904-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS Exxonmobil Research And Engineering Company (US) 2017-11-01 EP disclosed
EP-3237903-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS Exxonmobil Research And Engineering Company (US) 2017-11-01 EP disclosed
WO-2016106211-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 WO disclosed
US-20160187315-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 US disclosed
WO-2016106214-A1 METHODS FOR DETERMINING CONDITION AND QUALITY OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 WO disclosed
US-20160187314-A1 METHODS FOR AUTHENTICATION AND IDENTIFICATION OF PETROLEUM PRODUCTS EXXONMOBIL RESEARCH AND ENGINEERING COMPANY (US) 2016-06-30 US disclosed
US-20050288351-A1 Azaspiro compounds for the treatment of pain SCHWARZ PHARMA AG (DE) 2005-12-29 US disclosed
EP-1485352-B1 AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN SANOL ARZNEI SCHWARZ GMBH (DE) 2005-06-29 EP disclosed
EP-1520854-A2 Aza-Spirocompounds for the treatment of pain SCHWARZ PHARMA AG (DE) 2005-04-06 EP disclosed
EP-1485352-A1 AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN SCHWARZ PHARMA AG (DE) 2004-12-15 EP disclosed
WO-2003074486-A1 AZASPIRO COMPOUNDS FOR THE TREATMENT OF PAIN SCHWARZ PHARMA AG (DE) 2003-09-12 WO disclosed
US-4228179-A ANTICONVULSANTS WARNER-LAMBERT COMPANY (US) 1980-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288351-A1 Azaspiro compounds for the treatment of pain TPMT, P2RY13, OPRL1 OPRM1 32/4885OPRL1 3/4885SMN1; SMN2 1807/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.